Various clinical features of patients with anti-Hu associated paraneoplastic neurological syndromes: An observational study

Medicine (Baltimore). 2018 May;97(18):e0649. doi: 10.1097/MD.0000000000010649.

Abstract

To describe and analyze the clinical features and prognosis of patients with anti-Hu associated paraneoplastic neurological syndromes (PNS).The symptoms, MRI findings, cerebrospinal fluid (CSF) changes, electroencephalogram (EEG) characteristics and prognoses of 9 well-diagnosed anti-Hu associated PNS patients were analyzed.The study enrolled 6 female and 3 male patients. Three patients presented with vertigo and 6 patients exhibited a depressed mood, numbness of the lower limbs, generalized pains, seizures, mental disturbances, and a temporary unilateral hand tremor on initial presentation. Three patients presented with MRI abnormalities localized in the mesial temporal lobe and the thalamus. Abnormal interictal EEG readings were observed in all 5 patients who underwent EEG study. Four patients were found lung cancer (3 during hospitalization, 1 during follow-up). Seven patients were treated with immunotherapy and improved in symptoms. Three patients died during follow-up (2 with lung cancer).The clinical manifestation of anti-Hu associated PNS is diverse and multifocal. EEG may be more sensitive than MRI for early diagnosis of PNS. Long-term follow-up for patients with CT-negative anti-Hu associated PNS is necessary.

Publication types

  • Observational Study

MeSH terms

  • Aftercare
  • Autoantibodies / analysis*
  • Cerebrospinal Fluid / immunology
  • China / epidemiology
  • Diagnosis, Differential
  • Disease Management
  • ELAV Proteins / immunology*
  • Early Diagnosis
  • Electroencephalography / methods
  • Female
  • Humans
  • Magnetic Resonance Imaging / methods
  • Male
  • Middle Aged
  • Neuroimaging / methods
  • Paraneoplastic Syndromes, Nervous System* / diagnosis
  • Paraneoplastic Syndromes, Nervous System* / epidemiology
  • Paraneoplastic Syndromes, Nervous System* / immunology
  • Paraneoplastic Syndromes, Nervous System* / therapy

Substances

  • Autoantibodies
  • ELAV Proteins